Dr Chari on the Use of Ide-Cel and Cilta-Cel in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MD, discusses the use of the CAR T-cell therapies idecabtagene vicleucel and ciltacabtagene autoleucel in the treatment of patients with multiple myeloma.

Related Keywords

,Helen Diller Family Comprehensive Cancer Center ,Myeloma Program ,Ajai Chari ,Multiple Myeloma Program ,Diller Family Comprehensive Cancer Center ,Ucsf Helen Diller Family Comprehensive Cancer Center ,Onclive Tv ,Cart Cell Therapy ,Multiple Myeloma ,